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Flexner and Lewis (1), in connection with their studies of the pro- 
tective and therapeutic powers of convalescent serum in experimental 
poliomyelitis,  employed  the  method  of  reinoculation  of  virus  in 
recovered monkeys to increase the strength or potency of this  serum. 
The procedure was largely empirical, as no actual quantitative estima- 
tions of neutralizing action before and after  the  reinoculations were 
made.  The impression gained, however, was  that  reinoculation did 
increase the potency of the sermn. 
Monkey immune serm~ as now employed for experimental purposes 
may be considered to be of two sorts:  convalescent serum in  the true 
sense,  and  serum  derived  from  monkeys actively  immunized with 
virus  introduced by  various  routes  without  symptoms of infection 
appearing at any time.  In practical experiments, little or no distinc- 
tion has been made between these two kinds of immune sera, and no 
exact quantitative neutralization comparisons have been carried out. 
Stewart and Rhoads (2) have, however, shown thatmonkeyserummay 
be virus neutralizing in vitro  when the actively immunized animals 
yielding it  are  incapable of withstanding an  intracerebral injection 
of a highly potent virus.  This experimental discrepancy between the 
in vivo and in vitro inactivating power of immune sera is instructive in 
that it not only indicates quantitative variations in immune power, 
but suggests that  human beings also may yield neutralizing serum 
without themselves being completely or enduringly protected against 
the pathogenic action of a highly infectious virus strain. 
In order to decide whether or not quantitative differences in various 
immune sera actually existed, a  simple experiment was carried out. 
Monkeys which had recovered from typical poliomyelitis were repeat- 
edly reinoculated with large  amounts of  active poliomyelitis virus, 
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and  the  neutralizing  value  of  serum  obtained  before  and  after  the 
treatments  was  determined.  The  details  of  the  experiment  are  as 
follows: 
Reinforcement.--Six  Macacus  rhesus  monkeys,  which  had  survived  typical 
attacks of experimental poliomyelitis and still showed residual paralyses 15 to 19 
months  after  the  original inoculation,  were  selected.  Each  was  bled  20  cc., 
and the serum from the individual bleedings was separated in the usual manner. 
The several sera were pooled, and the resulting mixture was stored, unpreserved 
by  Chemicals,  at  4°C.  The  "reinforcing"  injections were  begun  immediately 
after the first bleeding and  conducted in the following manner.  A  5  per cent 
suspension of glycerolated nervous tissue of the "pooled mixed" virus strain was 
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employed in physiological saline solution.  The intradermal route of inoculation 
was selected, since Stewart and Rhoads  (2)  had shown that  route to be more 
effective than subcutaneous inoculation for giving rise to an active immunity in 
monkeys.  15  cc.  of the material was  introduced in each set  of injections by 
forming multiple superficial blebs.  The treatments were repeated 10 times at 3 
day intervals.  Thus a total of 150 cc. of virus was given in 30 days.  After a rest 
period of 1 month, the animals were bled, and the serum was separated, pooled, 
and stored as before.  The monkeys were carefully observed to detect any evidence 
of recurring symptoms durin~the injections, and none whatever was seen.  The 
technique of reinforcement is summarized in Table I. 
Neutralization  before Rei~forcement.--In  determining the  effectiveness of  the 
serum,  the usual in vitro technique was employed.  The fresh Berkefeld filtrate 
virus was mixed with the serum to be tested, kept an hour at 20°C., and inoculated 
intracerebrally into normal monkeys of approximately the same size. C.  P. RItOADS  139 
Tables II and III are consistent in showing that, given a  constant potent virus 
filtrate used in amounts of 0.12 cc., the pooled convalescent monkey serum before 
reinforcement was ineffective in quantities less than 0.75  to  1  cc.  A  sample  of 
pooled human  convalescent serum in a  volume of 0.1  cc. neutralized effectively 
in one test (Table  III). 
Although the meaning of the test is not at once clear, it is well worth 
recording that in  two instances a  single sample of a  human  serum, 
taken from a child 8 years old who had never shown  clinical evidence 
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of poliomyelitis, effected neutralization in the proportion of serum 0.1 
cc. and virus filtrate 0.12  cc.  This observation is in conformity with 
earlier experiments of Anderson and Frost  (3), in which supposedly 
normal human serum was found to be inactivating, and with recent 
tests by Aycock and Kramer (4).  The latter attribute the inactivat- 
ing power of the  serum to nonclinical mass immunization to the virus 
of poliomyelitis. 
Neutralization after Reinforcement.--Table IV, which includes three 
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the pooled reinforced serum contained greater quantities of neutraliz- 
ing antibodies than did the original pooled convalescent serum from 
the same monkeys.  The fact is even more striking in that, so far as 
the  tests  were carried,  there is  clear indication  that  the reinforced 
serum  possessed  neutralizing  value  equal  to  that  of  pooled  con- 
valescent human serum.  A  discrepancy will be noted  between the 
series  of  animals  inoculated  March  5,  1930, and  the  experiment 
summarized in Table III; in the  former instance 0.5  and 0.25  cc. of 
TABLE  III 
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non-reinforced  serum  protected  against  0.12  cc.  of  virus  filtrate, 
although 0.1  cc. failed to do so.  The probable  reason for this  differ- 
ence is to be found in the virus filtrate.  A  degree of inconstancy is 
encountered even in dealing with the most highly potent virus strains, 
for which adequate explanation is not at hand.  The filtrate prepared 
from an occasional monkey, sacrificed promptly after the appearance 
of paralytic symptoms, proves  somewhat less. active than  the rule. 
Whether the fault is due to the quantity of virus units in the nervous c.  P.  ~OADS  141 
system  of  a  particular  animal,  or  is  influenced  adversely  by  the 
operation  of  extracting  it,  is not  known.  On  the  whole,  however, 
this series of experiments was remarkably regular. 
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There is a practical side to these observations.  Hereafter  in testing 
the prophylactic and therapeutic value of convalescent monkey serum 
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human serum,  either as  a  prophylactic or  therapeutic measure,  it 
may be desirable to employ not merely convalescent, but reinforced 
convalescent monkey serum.  If  sertun  from  actively  immunized 
monkeys is also employed, preliminary tests of neutralizing power are 
desirable.  Undoubtedly certain discrepancies and failures of experi- 
ments are traceable to the use of weak convalescent monkey serum 
instead of the stronger human convalescent serum.  For experiments 
on  monkeys  the  homologous  reinforced  monkey  serum  may  be 
desirable. 
SUM~4~RY 
A  comparison has been made of the neutralizing value of pooled 
convalescent monkey serum for  the  filtered virus  of poliomyelitis, 
before and after a series of reinforcement  injections of the same virus 
strain. 
The strength of the pooled convalescent serum is increased by the 
reinforcing procedure. 
The original monkey convalescent serum had a neutralization value 
much below that of a pooled human convalescent  serum.  By reinforce- 
ment  the  neutralization value  of  the  monkey serum  was  brought 
approximately to that of the human serum. 
One sample of serum from a  supposedly normal child of 8 years 
exhibited  a  neutralizing  value  approximately  equal  to  that  of  a 
pooled human convalescent serum and the reinforced pooled monkey 
serum. 
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